In our study, GPT2 knockdown reduced the proportion of BCa stem cell subsets, suppressed cancer cell proliferation, and downregulated the CSC markers (ALDH1A1, SOX2, OCT4, and KMT1A). This evidence concerns the gene GPT2 and cancer.